Timing of basiliximab induction and development of acute rejection in lung transplant patients

Journal of Heart and Lung Transplantation

Volumn 30, Issue 11, 2011, Pages 1228-1235

  Swarup, Rajeev ^a   Allenspach, Lisa L ^a   Nemeh, Hassan W ^a   Stagner, Lisa D ^a   Betensley, Alan D ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

basiliximab; bronchiolitis obliterans; graft rejection; immunosuppression; lung transplant

Indexed keywords

ALPHA 1 ANTITRYPSIN; BASILIXIMAB; GANCICLOVIR; ITRACONAZOLE; METHYLPREDNISOLONE; SULFAMETHOXAZOLE; TRIMETHOPRIM; VALGANCICLOVIR; VORICONAZOLE;

ACUTE GRAFT REJECTION; ARTICLE; BRONCHIOLITIS OBLITERANS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFECTION PREVENTION; LUNG ASPERGILLOSIS; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MYCOSIS; OUTCOME ASSESSMENT; PNEUMOCYSTOSIS; PREMEDICATION; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; BRONCHIOLITIS OBLITERANS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LUNG TRANSPLANTATION; MALE; MICHIGAN; MIDDLE AGED; PREOPERATIVE CARE; RECEPTORS, INTERLEUKIN-2; RECOMBINANT FUSION PROTEINS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 80053961801     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2011.05.009     Document Type: Article

References (33)

1. J.D. Christie, L.B. Edwards, and P. Aurora The registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult lung and heartlung transplantation report2009 J Heart Lung Transplant 28 2009 1031 1049
2. M. Estenne, and M.I. Hertz Bronchiolitis obliterans after human lung transplantation Am J Respir Crit Care Med 166 2002 440 444
3. E.P. Trulock, L.B. Edwards, and D.O. Taylor Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heartlung transplantation report2006 J Heart Lung Transplant 25 2006 880 892 (Pubitemid 44143015)
4. M. Estenne, J.R. Maurer, and A. Boehler Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria J Heart Lung Transplant 21 2002 297 310 (Pubitemid 34224094)
5. A.P. Khalifah, R.R. Hachem, and M.M. Chakinala Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome Am J Transplant 5 2005 2022 2030 (Pubitemid 41039881)
6. A. El-Gamel, E. Sim, and P. Hasleton Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation J Heart Lung Transplant 18 1999 828 837 (Pubitemid 29469442)
7. R.E. Girgis, I. Tu, and G.J. Berry Risk factors for the development of obliterative bronchiolitis after lung transplantation J Heart Lung Transplant 15 1996 1200 1208 (Pubitemid 26428395)
8. C.A. Keller, P.T. Cagle, and R.W. Brown Bronchiolitis obliterans in recipients of single, double, and heartlung transplantation Chest 107 1995 973 980
9. K. Bando, I.L. Paradis, and S. Similo Obliterative bronchiolitis after lung and heart & ndasg; lung transplantation An analysis of risk factors and management J Thorac Cardiovasc Surg 110 1995 4 13
10. A.N. Husain, M.T. Siddiqui, and E.W. Holmes Analysis of risk factors for the development of bronchiolitis obliterans syndrome Am J Respir Crit Care Med 159 1999 829 833 (Pubitemid 29137781)
11. T.J. Kroshus, V.R. Kshettry, and K. Savik Risk factors for the development of bronchiolitis after lung transplantation J Thorac Cardiovasc Surg 114 1997 195 202 (Pubitemid 27364208)
12. D. Heng, L. Sharples, and K. McNeil Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors J Heart Lung Transplant 17 1998 1255 1263 (Pubitemid 29013408)
13. P.M. Hopkins, C.L. Aboyoun, and P.N. Chhajed Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis Am J Respir Crit Care Med 170 2004 1022 1026 (Pubitemid 39425700)
14. E.R. Garrity Jr, J. Villaneuva, and S.M. Bhorade Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody Transplantation 71 2001 773 777 (Pubitemid 32373693)
15. R.R. Hachem, M.M. Chakinala, and R.D. Yusen A comparison of basilixmab and anti-thymocyte globulin as induction agents after lung transplantation J Heart Lung Transplant 24 2005 1320 1326 (Pubitemid 41247816)
16. G. Ailawadi, P.W. Smith, and T. Oka Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation J Thorac Cardiovasc Surg 135 2008 594 602
17. D.B. Kaufman, R. Shapiro, and M.R. Lucey Immunosuppression: practice and trends Am J Transplant 4 suppl 9 2004 38 53 (Pubitemid 38858994)
18. R.R. Hachem, L.B. Edwards, and R.D. Yusen The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry Clin Transplant 22 2008 603 608
19. S.J. Swanson, S.J. Mentzer, and J.J. Reilly Surveillance transbronchial lung biopsies: implication for survival after lung transplantation J Thorac Cardiovasc Surg 119 2000 27 37
20. Novartis Pharmaceutical Corporation Simulect (basiliximab) monograph 1998 Norvartis Pharmaceutical Corporation Basel, Switzerland
21. N. Grundy, J. Simmonds, and H. Dawkins Pre-implantation basiliximab reduces incidence of early acute rejection in pediatric heart transplantation J Heart Lung Transplant 28 2009 1279 1284
22. G.J. Berry, E.M. Brunt, and D. Chamberlain A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection J Heart Transplant 9 1990 593 601
23. R.R. Hachem, R.D. Yusen, and M.M. Chakinala A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation J Heart Lung Transplant 26 2007 1012 1018 (Pubitemid 47494659)
24. M. de la Torre, E. Pena, and M. Calvin Basiliximab in lung transplantation: preliminary experience Transplant Proc 37 2005 1534 1536 (Pubitemid 40712109)
25. J.M. Borro, M. de la Torre, and C. Miguelez Comparative study of basiliximab treatment in lung transplantation Transplant Proc 37 2005 3996 3998 (Pubitemid 43015235)
26. K.R. McCurry, A. Iacono, and A. Zeevi Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy J Thorac Cardiovasc Surg 130 2005 528 537 (Pubitemid 41074188)
27. T.E. Starzl, and R.M. Zinkernagel Antigen localization and migration in immunity and tolerance N Engl J Med 339 1998 1905 1913 (Pubitemid 29013935)
28. C.M. Burton, C.B. Andersen, and A.S. Jensen The incidence of acute cellular rejection after lung transplantation: a comparative study of anti-thymocyte globulin and daclizumab J Heart Lung Transplant 25 2006 638 647 (Pubitemid 43766583)
29. J.C. Mullen, A. Oreopoulus, and D.C. Lien A randomized, controlled trial of daclizumab vs anti-thymocyte globulin induction for lung transplantation J Heart Lung Transplant 26 2007 504 510 (Pubitemid 46602005)
30. J.A. Belperio, S.S. Weight, and M.C. Fishbein Chronic lung allograft rejection: mechanisms and therapy Proc Am Thorac Soc 6 2009 108 121
31. S.D. Moffatt, P. Demers, and R.C. Robbins Lung transplantation: a decade of experience J Heart Lung Transplant 24 2005 145 151 (Pubitemid 40215588)
32. D.M. Meyer, L.E. Bennett, and R.J. Novick Single vs bilateral, sequential lung transplantation for end-stage emphysema: influence of recipient age on survival and secondary end-points J Heart Lung Transplant 20 2001 935 941 (Pubitemid 32824138)
33. A. Zuckermann, H. Reichenspurner, and T. Birsan Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial J Thorac Cardiovasc Surg 125 2003 891 900 (Pubitemid 36457511)